References

• 2003Sustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia630 cited
• 2005An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia434 cited
• 2000Zolpidem317 cited
• 2004Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia294 cited
• 1995Clinical Pharmacokinetics and Pharmacodynamics of Zolpidem273 cited
• 2006Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia265 cited
• 2004Comparative Pharmacokinetics and Pharmacodynamics of Short-Acting Hypnosedatives248 cited
• 1998Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII-R primary insomnia236 cited
• 2005An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia230 cited
• 1994A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.223 cited
• 2008Long-Term Efficacy and Safety of Zolpidem Extended-Release 12.5 mg, Administered 3 to 7 Nights Per Week for 24 Weeks, in Patients With Chronic Primary Insomnia: A 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study211 cited
• 2007Evaluation of the Efficacy and Safety of Ramelteon in Subjects with Chronic Insomnia197 cited
• 1999Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic